I haven't quite worked out what this is all about, but it seems that Prof is collaborating with some company to help with his T cell research.
http://www.prweb.com/releases/2016/09/prweb13691284.htm
This is what the other company says about Prof's company, Cellular Therapeutics Ltd.
Cellular Therapeutics Ltd is one of only a few groups in the world that
has achieved strong clinical responses with TIL therapies. They are also
leaders in manufacturing and validation of engineered adoptive T cell
therapies. We are excited to bring our unique TCR drug discovery
platform to bear on T cells that they provide us,” said David Johnson,
PhD, CEO of GigaGen. “
With this collaboration we are closer to
successfully achieving our goal of developing innovative, curative
therapies based on immune cells from cancer patients.
Let's hope so - and let's hope the therapies are affordable for the NHS!
Quent has another scan on Monday so we're off to Manchester again. Lunch first with the lovely Philip and Sue, whom we met at the Christie in 2007, when Quent and Philip were both undergoing IL-2. Then bloods, then the scan, then an appointment with Prof Trainer (endocronology) and then an appointment with Prof Hawkins, hopefully to get the results of the scan.